Real-world Data on the First-Line Immune Checkpoint Inhibitors or in Combination with Chemotherapy in Older Patients (aged ≥ 75 Years) with Advanced Non-Small Cell Lung Cancer
Heliyon(2024)
Key words
Non-small cell lung cancer,Older patients,Immunotherapy
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined